GlassScriptPhysician profile
Aaron Joseph Reich
NPI 1003388265
$1,090.73
in general payments reported to CMS, 2019-2025
21 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.18 · 2022: $153 · 2023: $262 · 2024: $242 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.76 | 2022-2025 | Relistor, Trulance |
| Averitas Pharma INC. | $185.20 | 2024-2025 | Qutenza |
| Nevro Corp. | $108.42 | 2022-2023 | Senza |
| Corcept Therapeutics | $89.05 | 2023 | Korlym |
| Merz Pharmaceuticals, LLC | $79.74 | 2025 | Xeomin |
| Azurity Pharmaceuticals, INC. | $56.04 | 2023-2025 | Horizant, Horizant |
| Abbvie INC. | $55.28 | 2025 | |
| Boston Scientific Corporation | $48.70 | 2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Novo Nordisk INC | $32.57 | 2022-2024 | Ozempic, Rybelsus |
| Dexcom, INC. | $31.19 | 2024 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $28.10 | 2021 | |
| Lilly USA, LLC | $22.37 | 2021 | |
| Medtronic, INC. | $19.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.65 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.40 | 2023 | Seglentis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.20 | 2023 | |
| Sun Pharmaceutical Industries INC. | $16.60 | 2025 | |
| International Rehabilitative Sciences, INC | $14.70 | 2023 | Rs 4i Plus Sequential Stimulator |
| Radius Health, INC. | $13.46 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.23 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Reich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.